Advertisement
U.S. Markets closed

Avecho Biotechnology Limited (AVE.AX)

ASX - ASX Delayed Price. Currency in AUD
0.00200.0000 (0.00%)
At close: 04:10PM AEDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
473.551
473.551
1,206
793.6
384.627
-
Cost of Revenue
517.346
517.346
336.142
285.663
143.715
-
Gross Profit
-43.795
-43.795
870.025
507.937
240.912
-
Operating Expense
4,724
4,724
3,857
5,059
3,648
-
Operating Income
-4,768
-4,768
-2,987
-4,551
-3,407
-
Net Non Operating Interest Income Expense
20.16
20.16
-2.002
-9.444
-5.133
-
Other Income Expense
1,132
1,132
646.569
1,144
777.296
-
Pretax Income
-3,437
-3,437
-2,342
-3,416
-2,635
-
Tax Provision
0
0
0
0
0
-
Net Income Common Stockholders
-3,437
-3,437
-2,342
-3,416
-2,635
-
Basic EPS
-0.00
-
-0.00
-0.00
-0.00
0.00
Diluted EPS
-0.00
-
-0.00
-0.00
-0.00
0.00
Basic Average Shares
1,884,450
-
1,837,785
1,802,269
1,591,078
1,577,457
Diluted Average Shares
1,884,450
-
1,837,785
1,802,269
1,591,078
1,577,457
Net Income from Continuing & Discontinued Operation
-3,437
-3,437
-2,342
-3,416
-2,635
-
Normalized Income
-3,437
-3,437
-2,342
-3,416
-2,634
-
Interest Income
35.516
35.516
4.347
0.531
0.792
-
Interest Expense
15.356
15.356
6.349
9.975
5.925
-
Net Interest Income
20.16
20.16
-2.002
-9.444
-5.133
-
EBIT
-3,421
-3,421
-2,336
-3,406
-2,629
-
EBITDA
-3,243
-3,243
-2,106
-2,978
-2,092
-
Reconciled Cost of Revenue
517.346
517.346
336.142
285.663
143.715
-
Reconciled Depreciation
178.695
178.695
230.351
428.594
536.629
-
Net Income from Continuing Operation Net Minority Interest
-3,437
-3,437
-2,342
-3,416
-2,635
-
Total Unusual Items Excluding Goodwill
-
-
-
-
-0.388
-108.617
Total Unusual Items
-
-
-
-
-0.388
-108.617
Normalized EBITDA
-3,243
-3,243
-2,106
-2,978
-2,092
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
0
0
0
0
0
-